279 related articles for article (PubMed ID: 9887052)
21. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum.
Hansen G; Schuster A; Zubrod C; Wahn V
Respiration; 1995; 62(3):117-24. PubMed ID: 7569330
[TBL] [Abstract][Full Text] [Related]
22. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
Carlson M; Peterson C; Venge P
Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
[TBL] [Abstract][Full Text] [Related]
23. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
[TBL] [Abstract][Full Text] [Related]
24. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Goldstein W; Döring G
Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
[TBL] [Abstract][Full Text] [Related]
25. Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease.
Rubio F; Cooley J; Accurso FJ; Remold-O'Donnell E
Thorax; 2004 Apr; 59(4):318-23. PubMed ID: 15047952
[TBL] [Abstract][Full Text] [Related]
26. Sputum ECP levels correlate with parameters of airflow obstruction.
Virchow JC; Hölscher U; Virchow C
Am Rev Respir Dis; 1992 Sep; 146(3):604-6. PubMed ID: 1519835
[TBL] [Abstract][Full Text] [Related]
27. Releasability of human hypereosinophilic eosinophils is related to the density of the cells.
Carlson M; Oberg G; Peterson C; Venge P
Br J Haematol; 1994 Jan; 86(1):41-7. PubMed ID: 8011546
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma.
Wark PA; Johnston SL; Moric I; Simpson JL; Hensley MJ; Gibson PG
Eur Respir J; 2002 Jan; 19(1):68-75. PubMed ID: 11852895
[TBL] [Abstract][Full Text] [Related]
29. Degranulation from human eosinophils stimulated with C3a and C5a.
Takafuji S; Tadokoro K; Ito K; Dahinden CA
Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):27-9. PubMed ID: 8156000
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte elastase-mediated proteolysis of alpha 1-antitrypsin in cystic fibrosis bronchopulmonary secretions.
Cantin A; Bilodeau G; Bégin R
Pediatr Pulmonol; 1989; 7(1):12-7. PubMed ID: 2788857
[TBL] [Abstract][Full Text] [Related]
31. Eosinophil and neutrophil degranulation in ophthalmic lesions of Wegener's granulomatosis.
Trocme SD; Bartley GB; Campbell RJ; Gleich GJ; Leiferman KM
Arch Ophthalmol; 1991 Nov; 109(11):1585-9. PubMed ID: 1755742
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents.
Hällgren R; Colombel JF; Dahl R; Fredens K; Kruse A; Jacobsen NO; Venge P; Rambaud JC
Am J Med; 1989 Jan; 86(1):56-64. PubMed ID: 2535919
[TBL] [Abstract][Full Text] [Related]
33. Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma.
Gutiérrez V; Prieto L; Torres V; Trenor R; Pérez C; Bertó JM; Marín J
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):559-65. PubMed ID: 10400484
[TBL] [Abstract][Full Text] [Related]
34. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
Egesten A; Malm J
Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
[TBL] [Abstract][Full Text] [Related]
35. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
36. alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis.
O'Connor CM; Gaffney K; Keane J; Southey A; Byrne N; O'Mahoney S; Fitzgerald MX
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1665-70. PubMed ID: 8256917
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil collagenase in sputum from patients with cystic fibrosis.
Power C; O'Connor CM; MacFarlane D; O'Mahoney S; Gaffney K; Hayes J; FitzGerald MX
Am J Respir Crit Care Med; 1994 Sep; 150(3):818-22. PubMed ID: 8087357
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil Proteases Activate Eosinophil Function in vitro.
Hiraguchi Y; Nagao M; Hosoki K; Tokuda R; Fujisawa T
Int Arch Allergy Immunol; 2008; 146 Suppl 1():16-21. PubMed ID: 18504401
[TBL] [Abstract][Full Text] [Related]
39. [Eosinophil and neutrophil degranulation in allergic inflammation: immunohistochemical localization of granule proteins in fatal asthma and stimulus-dependent degranulation in vitro].
Fujisawa T; Kita H; Sur S; Kobayashi K
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():115-24. PubMed ID: 8007454
[TBL] [Abstract][Full Text] [Related]
40. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
